Coagulation Analyzer Market Size Report & Global Overview 2030

Coagulation Analyzer Market Forecast to 2030 - Global Analysis By Product Type (Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers), Test (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, D-Dimer Testing, Activated Partial Thromboplastin Time Testing, Platelets Function Testing, and Others), Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospital, and Others), and Geography

Publication Month : Aug 2023

  • Report Code : TIPRE00008957
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 205
Inquire Before Buy



[Research Report] The coagulation analyzer market size is expected to grow from US$ 4,183.71 million in 2022 to US$ 6,690.08 million by 2030; it is estimated to register a CAGR of 6.0% from 2022 to 2030.

Analyst’s ViewPoint

The coagulation analyzer market analysis include driving factors such as rising prevalence of blood disorders among the population and growing incidence of cardiovascular diseases. Further, point-of-care testing coagulation analyzers acts as a future trend for the market to grow during 2022–2030. According to the segmentation profiled in the report, based on product type segment, the clinical laboratory analyzers segment accounted the largest share in 2020. In terms of test type, the 2D prothrombin time testing segment dominated the market by accounting maximum share. By technology, the optical technology segment will account a considerable share for the coagulation analyzers to dominate the market growth during the forecast period. Based on application, the clinical laboratories segment is expected to account the maximum share for the coagulation analyzers market growth during 2022–2030.

Coagulation analyzers measure blood platelet levels in a fast and simple process. A coagulation analyzer is used for measuring a coagulation pathway speed checking thrombolin and thromboplastin levels in low as in a few minutes. Also, several top companies are manufacturing innovative coagulation analyzers for hemostasis testing. The Sysmex CS-2500 system is one such example that employs smartly designed technologies involving assay-based preanalytical sample-quality checks using PSI technology, automated mixing studies, automated platelet aggregation, and clot waveform analysis. Such automated processes improve efficiency, exceptional accuracy, and reliable first-run results.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Coagulation Analyzer Market: Strategic Insights

Market Size Value inUS$ 4,183.71 million in 2022
Market Size Value byUS$ 6,690.08 million by 2030
Growth rateCAGR of 6.0% from 2022 to2030
Forecast Period2022-2030
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Insights

Rising Prevalence of Blood Disorders

A coagulation analyzer is a device that measures and evaluates the speed of clot formation or clot coagulation. It provides a fast, simple way to measure blood platelet levels and thrombolin and thromboplastin levels accurately. According to the National Organizations of Rare Disorders, hemophilia A is a common X-linked recessive disorder and the second most common inherited clotting factor deficiency after von Willebrand disease. In the US, approximately 1 in 5,000 newborn males suffer from hemophilia A. According to the National Library of Medicine (NLM), in 2020, approximately 30,000-33,000 males were affected with hemophilia in the US. According to the US Department of Health & Human Services, in 2020, ~100,000 Americans had sickle cell disease (SCD), the most commonly inherited blood disorder. Furthermore, by 2050, the number of people suffering from SCD is expected to grow by ~30%. As per the National Library of Medicine, in 2022, ~1% of all individuals (unselected population) are suffering from von Willebrand disease, i.e., 125 per 1 million. Similarly, in European Union, 80 million people suffer from blood disorders, ranging from cancer to bleeding disorders, as per research published in NLM in 2020. According to National Organization for Rare Disorders, in 2022, in the US immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affects approximately 66 adults per 1 million each year. Moreover, in the US, the incidence of ITP in adults is ~3.3 per 100,000/year, while the prevalence is 9.5 per 100,000. Thus, the increasing prevalence of blood disorders is driving the coagulation analyzers market growth.

Development of Point-of-Care (POC) Coagulation Analyzers

A rapid, reliable assessment of hemostasis is essential for patients with trauma or other bleeding problems. Due to the requirements of sample preparation and the analytical process, routine coagulation assays cannot visualize the process of clot formation, and their results are obtained only after 30–90 minutes. Point-of-care (POC) devices such as viscoelastic coagulation tests, platelet function tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used both inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzer provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians' offices, these devices can assist with patient management in pharmacies, care centers, and patients' homes. POC coagulation analyzer offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.

In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. Siemens Healthineers' Xprecia Stride Coagulation Analyser was cleared by the FDA as a POC coagulation analyzer device. The device has demonstrated PT/INR (i.e., prothrombin time/international normalized ratio) testing performance equivalence to Roche CoaguChek XS.

Thus, the growing development of POC coagulation analyzers is likely to propel the market growth during the forecast period.

Report Segmentation and Scope

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Product Type-Based Insights

Based on product type, the coagulation analyzers market is segmented as clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers is further bifurcated into system and consumables. The clinical laboratory analyzers segment held a larger market share in 2022. The point-of-care testing analyzers accounted a significant CAGR for the coagulation analyzers market. Point of care (POC) testing analyzers are used to obtain results of the blood protein. These analyzers are used in doctors’ offices, hospitals. POCT testing analyzers offer quick feedback on several medical tests.

Benefit of POCT

  • Portability
  • Convenience
  • Speed
  • Connectivity
  • Sample Quality
  • Quality Assurance

These devices measure electrochemical, optical, and mechanical parameters of clotting blood. POC tests for coagulation monitoring, with the help of various activators, play an important role in detecting bleeding disorders and monitoring of anticoagulant drugs. In this regard, advanced technologies such as microfluidics, fluorescent microscopy, electrochemical sensing, photoacoustic detection, and micro/nano electromechanical systems have been employed to develop highly accurate, robust, and cost-effective POC devices, e.g., Roche Diagnostics CoaguChek XS System, and ARKRAY, Inc. SPOTCHEM HS HS-7710.

Test Type-Based Insights

Based on test type, the global coagulation analyzers market is segregated into prothrombin time testing, fibrinogen testing, D-dimer testing, platelets function testing, activated clotting time testing, activated partial thromboplastin time testing, and others. The prothrombin time testing segment accounted the largest market share in 2022. The D-dimer testing segment is expected to grow at the highest CAGR during the forecast period. A prothrombin time (PT) is a test used to help detect and diagnose a bleeding disorder or excessive clotting disorder; the international normalized ratio is calculated from a PT result and is used to monitor the blood-thinning medication (anticoagulant) warfarin (Coumadin) working to prevent blood clots.

A PT measures the number of seconds it takes for a clot to form in sample of blood after substances (reagents) are added. The PT is often performed along with a partial thromboplastin time (PTT) and together they assess the amount and function of proteins called coagulation factors that are an important part of proper blood clot formation.

A PT and INR are ordered on a regular basis when a person is prescribed to take anticoagulant drug warfarin to make sure that the drug is producing the desired effect.

Likewise, D-dimer tests are used to help rule out the presence of an inappropriate blood clot (thrombus). Some of the conditions that the D-dimer test is used to help rule out include Deep Vein Thrombosis, Stroke and Pullmonary Embolism. This test may be used to diagnose diseases and conditions that cause hypercoagulability—a tendency to clot inappropriately. A D-dimer level may also be used to help diagnose disseminated intravascular coagulation (DIC) and to monitor the effectiveness of DIC treatment.

D-dimer is one of the protein fragments produced when a blood clot gets dissolved in the body. It is normally undetectable or detectable at a very low level unless the body is forming and breaking down blood clots. Then, its level in the blood can significantly rise. This test detects D-dimer in the blood.

Technology-Based Insights

In terms of technology, the coagulation analyzers market is segmented as optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment accounted the largest coagulation analyzers market share in 2022. Optical coagulation analyzers are used together with the test reagents to deliver quick-lab quality results that support clinical decisions in cardiology, surgery, and intensive care. The Wondfo's point-of-care testing (POCT) coagulation analyzer is the first instrument that can test PT/INR/APTT, TT, FIB, and ACT. Likewise, viscoelastic properties of blood can be monitored by studying its optical properties either by through light scattering or light transmission. In laser speckle rheometers, light scattering due to the Brownian motion in the blood gives direct information about viscoelastic properties or coagulation of the blood. In order to measure this, the time-varying speckle intensity of fluctuations is measured by finding auto correlation curve from a series of image frames while the clotting blood is illuminated with a laser. LSR method also suggests a rapid assessment of anticoagulation status in real-time.

Application-Based Insights

By application, the market is segmented as clinical laboratories, hospitals, and others. The clinical laboratories segment held the highest market share in 2022 and will register highest CAGR during the forecast period. Clinical laboratories are healthcare facilities providing a wide range of laboratory procedures that aid the physicians in carrying out the diagnosis, treatment, and management of patients. Clinical laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible blood analysis in different parameters. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, and others. The increasing prevalence of chronic diseases, infectious diseases, lifestyle disorders is one of the major factors promoting the growth of the market.

Coagulation analyzers Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis

North America dominated the coagulation analyzers market accounting maximum share. In North America, the US is the largest market for coagulation analyzers. The growth of this market is primarily driven by increasing incidence of blood disorders, growing prevalence of cardiovascular diseases such as atrial fibrillation (AFib), developments by the market players, and presence of major market players in the US. As per the Centers for Disease Control and Prevention (CDC), in 2019, AFib was mentioned on ~183,321 death certificates in the US; it was the primary cause of death in nearly 26,535 of those deaths. It is anticipated that 12.1 million people will suffer from AFib by 2030 in the US. As per the Canadian Task Force on Preventive Health Care, the incidence of Atrial Fibrillation (AFib) in Canada increases by 4.5% per year, with lifetime risk of ~25% people older than 40 years. The increasing incidence of blood disorders is likely to propel the demand for coagulation analyzers. For instance, as per the CDC, Hemophilia A affects 1 in 5,000 male births. Nearly 400 babies are born with Hemophilia A each year. It also mentioned that ~33,000 males in the US were diagnosed with hemophilia during 2012–2018. Further, approximately 300,000 Canadians carry an inherited bleeding disorder gene. One in 10 of these people—at least 30,000 Canadians—have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of inherited bleeding disorder comprehensive care clinics.

The increasing awareness program for blood disorders is likely to the favor market growth for coagulation analyzers. Hemophilia Health Education and Prevention Funded Projects is the largest program in CDC’s division of blood disorders. CDC has funded projects that are designed to promote health and prevent complications related to bleeding disorders.

Thus, increasing number of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders in the region are anticipated to boost the North America coagulation analyzers market growth during the forecast period.

The report profiles leading players operating in the global coagulation analyzers market. These involve Abbott Laboratories, Danaher Corp, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corp, F. Hoffmann-La Roche Ltd, Maccura Biotechnology Co Ltd, and Bio Group Medical System SRL.

In February 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of the companies' long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement, Siemens Healthineers will distribute the new Sysmex CN Systems.

In July 2020, Sysmex announced the launch of a new product- “Automated Blood Coagulation Analyzers CN-6000 and CN-3000” in the EMEA region.

Company Profiles

  • Abbott Laboratories
  • Danaher Corp
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc
  • Sysmex Corporation
  • Horiba Ltd.
  • Nihon Kohden Corp
  • F. Hoffmann-La Roche Ltd
  • Maccura Biotechnology Co Ltd
  • Bio Group Medical System SRL
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, Test, Technology, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

Which segment led the Coagulation Analyzers market?

Based on product type, the clinical laboratory analyzers segment took the forefront lead in the global market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

What is meant by the Coagulation Analyzers market?

Coagulation analyzers measure blood platelet levels in a fast and simple process. The coagulation analyzer is used for measuring a coagulation pathway speed and thrombolin and thromboplastin levels in low as in a few minutes. Also, several top companies are manufacturing innovative coagulation analyzers for hemostasis testing. The Sysmex CS-2500 system is one such example that employs smartly designed technologies involving assay-based preanalytical sample-quality checks using PSI technology, automated mixing studies, automated platelet aggregation, and clot waveform analysis. Such automated processes improve efficiency, exceptional accuracy, and reliable first-run results.

What are the driving factors for the Coagulation Analyzers market across the globe?

Rising prevalence of blood disorders is a standalone factor responsible for driving the overall coagulation analyzers market growth during the forecast period.

Which test type segment held the largest revenue (US$ Mn) in the Coagulation Analyzers market?

The prothrombin time testing segment dominated the global coagulation analyzers market and accounted for the largest revenue in 2022.

Who are the key players in the Coagulation Analyzers market?

Abbott Laboratories, Danaher Corp, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corp, F. Hoffmann-La Roche Ltd, Maccura Biotechnology Co Ltd, and Bio Group Medical System SRL, among others are among the leading companies operating in the global coagulation analyzers market.

The List of Report Companies - Coagulation Analyzers Market

  1. Abbott Laboratories
  2. Danaher Corp
  3. Siemens Healthcare GmbH
  4. Thermo Fisher Scientific Inc
  5. Sysmex Corporation
  6. Horiba Ltd.
  7. Nihon Kohden Corp
  8. F. Hoffmann-La Roche Ltd
  9. Maccura Biotechnology Co Ltd
  10. Bio Group Medical System SRL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports